Jul 20, 2026 08:30AM
May 5, 2026 04:34PM
May 5, 2026 04:01PM
Apr 29, 2026 08:00AM
Feb 12, 2026 04:30PM
Feb 12, 2026 04:01PM
Feb 5, 2026 04:05PM Ultragenyx to Host Conference Call for Fourth Quarter and Full-Year 2025 Financial Results and Corporate Update
Jan 12, 2026 07:31AM
Jan 12, 2026 07:30AM
Dec 29, 2025 12:04PM
Nov 4, 2025 04:19PM
Nov 4, 2025 04:05PM
Oct 28, 2025 04:30PM
Aug 5, 2025 04:01PM Ultragenyx Reports Second Quarter 2025 Financial Results and Corporate Update
Jul 30, 2025 08:30AM
Jul 9, 2025 04:05PM
Jul 9, 2025 04:05PM
May 6, 2025 04:48PM
May 6, 2025 04:01PM
Apr 30, 2025 05:00PM
Apr 2, 2025 07:04AM Smid cap biotech investors must stop chasing binary events says Cantor Fitzgerald
Feb 14, 2025 06:57AM
Feb 13, 2025 04:50PM
Feb 13, 2025 04:01PM
Feb 6, 2025 04:30PM
Jan 12, 2025 11:00AM
Dec 11, 2024 08:30AM
Nov 5, 2024 04:14PM Ultragenyx Pharma (RARE) Tops Q3 EPS by 8c, provides guidance
Nov 5, 2024 04:01PM
Oct 29, 2024 04:05PM
Aug 1, 2024 05:34PM
Aug 1, 2024 04:05PM
Jul 25, 2024 04:05PM
Jul 9, 2024 07:00PM
Jun 12, 2024 08:12AM Ultragenyx Pharma (RARE), Mereo BioPharma (MREO) Announce New Phase 2 Data from Phase 2/3 Orbit Study Demonstrating Sustained Reductions in Fracture Rates Following Treatment with Setrusumab (UX143) i
Jun 11, 2024 05:47PM
May 2, 2024 04:14PM
May 2, 2024 04:00PM
Apr 25, 2024 04:30PM
Apr 25, 2024 04:30PM
Apr 24, 2024 09:42AM
Feb 15, 2024 04:05PM Ultragenyx Pharma (RARE) Tops Q4 EPS by 18c
Feb 15, 2024 04:01PM
Feb 8, 2024 04:00PM
Jan 8, 2024 07:00AM
Jan 8, 2024 05:20AM
Jan 7, 2024 11:00AM
Nov 2, 2023 05:03PM
Nov 2, 2023 04:05PM Ultragenyx Reports Third Quarter 2023 Financial Results and Corporate Update
Oct 26, 2023 04:05PM

1,208,277 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All